TD Cowen maintains Revvity at Buy, raises price target to $185 from $175
TD Cowen reiterated its Buy rating on Revvity and increased its price target to $185 from $175, suggesting a 13.2% upside from the Nov 3 close of $163.48. Recent analyst price targets for Revvity range from $172 to $180.
How this was made
The 30-second read
Why it matters
This is primarily a sentiment/positioning input for RVTY rather than a fundamental update; it may influence near-term trading flows but does not change the company’s disclosed outlook in the text.
Market read
A higher analyst price target can nudge short-term sentiment, but the article lacks any new Revvity operational or financial datapoint.
What to watch
Traders may focus more on Revvity’s next earnings/guidance or any new trial/regulatory/product milestones, which are not mentioned here.
Background
The piece summarizes TD Cowen’s latest stance on Revvity, including a raised price target and the implied upside versus the Nov 3 close.
Ticker impact
TD Cowen maintained Revvity at Buy and raised its price target to $185 from $175, implying 13.2% upside from the Nov 3 close.
Likely modest upward bias as traders price in the higher target, with follow-through depending on broader analyst consensus.
The article contains only an analyst rating and price-target change, with no new Revvity fundamentals, guidance, or events.
Market effects
Limited sector read-through because the update is a single-name analyst target change without new sector data.
Minimal, as the catalyst is company-specific and not a macro release.
Low, no cross-border deal, regulation, or supply-chain shock is described.
Counterpoint
If the stock already reflects prior analyst optimism, a higher target may have limited incremental impact versus valuation and upcoming company-specific catalysts.
Key entities
- companyRevvity
Subject of the analyst action: maintained Buy and raised price target to $185 from $175.
- analyst_firmTD Cowen
Brokerage issuing the rating maintenance and price-target increase.
